Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jauzac

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Experimental Neurology|August 1, 2000
Exofocal alterations in opioidergic receptor densities following focal cerebral ischemia in the mouseH Boutin, F Dauphin, P Jauzac, et al.
Neuropeptides|December 1, 1984
Solubilization of two molecular forms of the frog brain opioid receptorA Puget, B Frances, P Jauzac, et al.
Clinical Chemistry|May 1, 1982
Elimination of interference by acebutolol and its metabolites in determinations of urinary metanephrinesP Jauzac, C Sylla, P Valdiguie, et al.
Neuropeptides|December 1, 1984
Divalent cations: do they stabilize the agonist (12S) form of the mu opioid receptor?P Jauzac, B Frances, A Puget, et al.
Molecular Pharmacology|September 1, 1981
Opiate receptors in the rat brain. Specific labeling of multiple membrane components with [3H]etorphine?A Puget, P Jauzac, J M Zajac, et al.
Journal of Neurochemistry|April 1, 1997
The delta-opioid receptor in SK-N-BE human neuroblastoma cell line undergoes heterologous desensitizationN Namir, J Polastron, S Allouche, et al.
Stroke|June 4, 1999
Differential time-course decreases in nonselective, mu-, delta-, and kappa-opioid receptors after focal cerebral ischemia in miceH Boutin, F Dauphin, E T MacKenzie, et al.
European Neurology|January 1, 1978
Hemodynamic and metabolic factors in human cerebral ischemiaA Bes, P Jauzac, A Guell, et al.
The Biochemical Journal|August 5, 1999
Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BES Allouche, J Polastron, A Hasbi, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 1, 1982
Cerebral circulatory effects of a dopaminergic agonist (apomorphine) in the dogP Jauzac, A Blasco, F Vigoni, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Experimental Neurology|August 1, 2000
Exofocal alterations in opioidergic receptor densities following focal cerebral ischemia in the mouseH Boutin, F Dauphin, P Jauzac, et al.
Neuropeptides|December 1, 1984
Solubilization of two molecular forms of the frog brain opioid receptorA Puget, B Frances, P Jauzac, et al.
Clinical Chemistry|May 1, 1982
Elimination of interference by acebutolol and its metabolites in determinations of urinary metanephrinesP Jauzac, C Sylla, P Valdiguie, et al.
Neuropeptides|December 1, 1984
Divalent cations: do they stabilize the agonist (12S) form of the mu opioid receptor?P Jauzac, B Frances, A Puget, et al.
Molecular Pharmacology|September 1, 1981
Opiate receptors in the rat brain. Specific labeling of multiple membrane components with [3H]etorphine?A Puget, P Jauzac, J M Zajac, et al.
Journal of Neurochemistry|April 1, 1997
The delta-opioid receptor in SK-N-BE human neuroblastoma cell line undergoes heterologous desensitizationN Namir, J Polastron, S Allouche, et al.
Stroke|June 4, 1999
Differential time-course decreases in nonselective, mu-, delta-, and kappa-opioid receptors after focal cerebral ischemia in miceH Boutin, F Dauphin, E T MacKenzie, et al.
European Neurology|January 1, 1978
Hemodynamic and metabolic factors in human cerebral ischemiaA Bes, P Jauzac, A Guell, et al.
The Biochemical Journal|August 5, 1999
Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BES Allouche, J Polastron, A Hasbi, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 1, 1982
Cerebral circulatory effects of a dopaminergic agonist (apomorphine) in the dogP Jauzac, A Blasco, F Vigoni, et al.
Pageof 4